Invo BioScience - Stock Price History | INVO

Historical daily share price chart and data for Invo BioScience since 2021 adjusted for splits. The latest closing stock price for Invo BioScience as of September 27, 2021 is 3.35.
  • The all-time high Invo BioScience stock closing price was 9.40 on March 09, 2021.
  • The Invo BioScience 52-week high stock price is 12.30, which is 267.2% above the current share price.
  • The Invo BioScience 52-week low stock price is 2.90, which is 13.4% below the current share price.
  • The average Invo BioScience stock price for the last 52 weeks is 4.01.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Invo BioScience Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 2.8474 0.2494 4.8100 0.1500 3.0100 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.035B $0.001B
INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. It engages in the development and manufacture of its lead product, INVOcell, a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. INVO Bioscience focuses on selling its product to IVF centers and physicians through distributors, as well as directly to physicians in Europe, Canada, Latin America, and the Middle East.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29